Find my Regeneron Pharmaceuticals, Inc. 401(k) plan

Regeneron Pharmaceuticals, Inc. offers REGENERON PHARMACEUTICALS, INC. 401(K) SAVINGS PLAN through Fidelity. Their plan covers 7,397 employees.

Updated on Mar 06, 2024

Regeneron Pharmaceuticals, Inc. 401(k) plan information

Regeneron Pharmaceuticals, Inc.’s 401(k) provider
Plan name
REGENERON PHARMACEUTICALS, INC. 401(K) SAVINGS PLAN
Phone number
Fax number
Hours of operation
Monday - Friday: 8:30am - 12am EST, No weekend hours
Address
PO Box 770002, Cincinatti, OH, 45277-0090
To access your Regeneron Pharmaceuticals, Inc. 401(k) plan online, visit the Fidelity website and enter your username and password, or use the forgot login feature to reset your credentials. If you don’t have login credentials, try registering as a new user.
If you have a 401(k) plan through Regeneron Pharmaceuticals, Inc. at Fidelity and no longer work there, you have a few options. You can leave it with Fidelity, roll it over into an individual retirement account (IRA), roll it over into a new 401(k), or withdraw the funds (may incur tax penalties).

Get help finding your 401(k) plan from Regeneron Pharmaceuticals, Inc.

Our experts can guide you through the process to verify your identity and claim your account.

Regeneron Pharmaceuticals, Inc. 401(k) plan details

Regeneron Pharmaceuticals, Inc. offers REGENERON PHARMACEUTICALS, INC. 401(K) SAVINGS PLAN through Fidelity. Their plan covers 7,397 employees.

Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. is a leading biopharmaceutical company founded in 1988 by Leonard S. Schleifer and George Yancopoulos. Based in Tarrytown, NY, Regeneron has grown to become one of the largest employers in Westchester County with over 5,500 employees worldwide. The company’s mission is to use the power of science to bring new medicines to patients that help them live healthier and longer lives by producing breakthrough treatments for serious medical conditions such as high cholesterol, eye diseases, allergic and inflammatory conditions, cancer and infectious diseases. Regeneron focuses on developing innovative medicines through its research platform emphasizing antibody technologies that efficiently deliver drugs directly into cells and tissues where they can have maximum effect with minimum side effects for patients. This emphasis on high-impact innovation has resulted in multiple successful products being approved by the FDA including EYLEA® (aflibercept), Praluent® (alirocumab), Dupixent® (dupilumab) and Kevzara™ (sarilumab).
Headquarters
777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY 10591
Phone number
914-847-7400
Contact
LEONARD BROOKS
EIN
13-3444607